-+ 0.00%
-+ 0.00%
-+ 0.00%

HEALTH CANADA APPROVES SKYRIZI® (RISANKIZUMAB) FOR CHILDREN LIVING WITH MODERATE TO SEVERE PLAQUE PSORIASIS

Reuters·10/20/2026 12:01:00

Please log in to view news